Interventional Radiology Imaging

Which Biliary Procedure Is Best for a Liver Transplant Patient with Rising Bilirubin?

·
Which Biliary Procedure Is Best for a Liver Transplant Patient with Rising Bilirubin?

It’s 2 PM on a Tuesday, and you’re managing a patient six months post-orthotopic liver transplantation. Their latest labs show a steadily rising total bilirubin and alkaline phosphatase, but the ultrasound from this morning was unremarkable, specifically noting no intrahepatic or extrahepatic biliary ductal dilation. You suspect a biliary complication at the anastomosis—either a stenosis or a subtle leak—but the absence of dilated ducts complicates the typical diagnostic and therapeutic algorithm. The patient needs an intervention, but which one is the right first step? This article provides a clinical workflow for this specific scenario, guiding you through the differential, procedural rationale, and downstream decisions. Based on the American College of Radiology (ACR) Appropriateness Criteria, the initial therapeutic procedure of choice is an Endoscopic internal biliary catheter (removable plastic stent), which is rated Usually Appropriate.

Who Fits This Clinical Scenario?

This guidance applies specifically to liver transplant recipients who present with biochemical evidence of biliary obstruction (e.g., elevated bilirubin, alkaline phosphatase) but lack sonographic or cross-sectional imaging evidence of biliary ductal dilation. The core clinical suspicion is a post-transplant biliary complication, most commonly an anastomotic stenosis or a bile leak.

This workflow is distinct from several related but different clinical situations. This article does not apply if:

  • The patient has clearly dilated bile ducts. While the therapeutic options overlap, the pre-procedural certainty and technical approach may differ. This is a common finding in patients with biliary sepsis or choledocholithiasis.
  • The patient is not a transplant recipient. A bile leak after a standard laparoscopic cholecystectomy, for instance, involves a different anatomical context and set of considerations.
  • Malignant obstruction is suspected. A workup for a Klatskin tumor or pancreatic carcinoma involves a different diagnostic and staging pathway, where tissue acquisition is a primary goal.
  • Sclerosing cholangitis is the primary suspicion. While this can recur post-transplant, a de-novo workup for sclerosing cholangitis has its own dedicated ACR criteria.

The key feature of this scenario is the combination of a post-transplant patient, abnormal liver function tests suggesting cholestasis, and non-dilated ducts, pointing toward a focal, non-obstructive, or early obstructive process.

What Diagnoses Are You Working Up in This Scenario?

In a liver transplant recipient with rising bilirubin and non-dilated ducts, the differential diagnosis is narrow but critical. The primary goal of the initial therapeutic procedure is to both diagnose and treat the underlying cause.

Biliary Anastomotic Stenosis: This is the most common biliary complication following liver transplantation. It typically occurs at the site of the surgical connection (anastomosis) between the donor’s common bile duct and the recipient’s common bile duct. Ischemia, fibrosis, and surgical technique can all contribute. The stenosis creates a functional obstruction to bile flow, leading to cholestasis even before the upstream ducts have had time to dilate, or if the fibrosis prevents dilation.

Bile Leak: A leak can also occur at the anastomosis or from the cut surface of the liver (e.g., in a partial graft) or T-tube site. A contained leak may present insidiously with rising bilirubin as bile is reabsorbed, while a free leak often presents more acutely with pain and peritonitis. Without frank fluid collections on imaging, a subtle, contained leak can be difficult to diagnose non-invasively.

Non-Anastomotic (Ischemic) Strictures: Less common than anastomotic stenosis, these strictures occur within the biliary tree of the allograft itself, away from the surgical connection. They are often a result of hepatic artery thrombosis or stenosis, leading to ischemic injury of the bile duct epithelium. They can be multiple and are generally more difficult to treat than a focal anastomotic stenosis.

Recurrent Primary Disease: In patients transplanted for conditions like Primary Sclerosing Cholangitis (PSC), the disease can recur in the allograft, causing new strictures. Differentiating recurrent PSC from ischemic strictures or chronic rejection can be challenging and often requires a combination of cholangiography, biopsy, and clinical history.

Why Is an Endoscopic Internal Biliary Catheter the Recommended Initial Procedure?

For a liver transplant recipient with suspected anastomotic stenosis or leak and non-dilated ducts, the ACR designates placement of an Endoscopic internal biliary catheter (removable plastic stent) as Usually Appropriate. This procedure is performed via Endoscopic Retrograde Cholangiopancreatography (ERCP).

The rationale for this recommendation is multi-faceted. ERCP offers a combined diagnostic and therapeutic capability that is ideal for this scenario. During the procedure, a cholangiogram can directly visualize the biliary anatomy, definitively identifying the location and severity of a stenosis or demonstrating extravasation from a bile leak. If a stenosis is found, it can be immediately treated with balloon dilation followed by the placement of one or more removable plastic stents to maintain patency. If a leak is identified, placing a stent across the anastomosis reduces the pressure gradient, promoting preferential flow of bile into the duodenum and allowing the leak to heal.

Let’s compare this to the other rated procedures:

  • Percutaneous internal/external biliary catheter: This procedure, performed by Interventional Radiology, is also rated Usually Appropriate. It involves placing a drain through the skin and liver into the biliary tree. While highly effective, it is often considered a second-line option in this specific scenario because the non-dilated nature of the ducts makes percutaneous access technically challenging and increases the risk of complications like bleeding. However, it becomes the primary choice if the patient has a Roux-en-Y gastric bypass or other surgically altered anatomy that precludes standard ERCP access.
  • Surgery: Surgical revision is rated Usually not appropriate as an initial therapeutic step. It is significantly more invasive and carries higher morbidity. Endoscopic and percutaneous options are preferred first-line treatments, with surgery reserved for cases where these less invasive methods fail or are not anatomically feasible.
  • Permanent biliary metallic stent: This is rated Usually not appropriate. While metallic stents provide a larger and more durable lumen, they are difficult or impossible to remove. In a benign condition like a post-transplant anastomotic stenosis, the goal is to remodel the stricture with temporary stenting, not to place a permanent implant that could complicate future interventions or re-transplantation.

The endoscopic approach is favored as the initial step because it is less invasive than surgery, avoids an external catheter, and is highly effective for the most common underlying pathologies in this patient population.

What’s Next After the Procedure? Downstream Workflow

The results of the ERCP and stent placement will dictate the subsequent management plan. The workflow branches based on the intraprocedural findings.

If a focal anastomotic stenosis is found and stented: The patient will typically be scheduled for a repeat ERCP in approximately 3-6 months. The goal is “serial stenting,” where stents are exchanged and often increased in number or size over time to progressively dilate and remodel the fibrotic stricture. This process can take 12-24 months to achieve durable patency. Liver function tests are monitored closely in the interim.

If a bile leak is found and stented: The stent is typically left in place for 4-8 weeks to allow the leak to heal. A follow-up cholangiogram (either via repeat ERCP or sometimes a HIDA scan) may be performed to confirm resolution of the leak before the stent is removed. Most post-transplant bile leaks respond well to this approach.

If the ERCP is technically unsuccessful: The most common reason for failure is the inability to cannulate the bile duct. In this case, the next step is typically a referral to Interventional Radiology for the alternative Usually Appropriate procedure: a Percutaneous Transhepatic Cholangiography (PTC) with placement of a percutaneous biliary drain.

If the ERCP is negative (no stenosis or leak identified): This is a critical branch point. The absence of a biliary cause for the patient’s cholestasis prompts a broader workup for other causes of allograft dysfunction. This includes re-evaluating for hepatic artery or portal vein compromise with Doppler ultrasound or CTA/MRA, considering acute or chronic rejection (which requires a liver biopsy), or investigating medication-induced liver injury.

Pitfalls to Avoid (and When to Get Help)

Navigating this clinical scenario requires vigilance for several potential pitfalls. First, do not be falsely reassured by the absence of ductal dilation on ultrasound. In the post-transplant liver, fibrosis can prevent the ducts from dilating even in the presence of a significant functional obstruction. Persistently elevated cholestatic enzymes warrant further investigation.

Second, be aware of the patient’s post-surgical anatomy. If the patient has a Roux-en-Y hepaticojejunostomy, a standard ERCP is not possible. These patients require a referral for a balloon-assisted or device-assisted enteroscopy-ERCP or, more commonly, a direct referral to Interventional Radiology for percutaneous access.

Finally, recognize the risks of ERCP, primarily post-ERCP pancreatitis (PEP). While the risk is generally lower in post-transplant patients compared to those with native anatomy, it is not zero. Ensure appropriate post-procedural monitoring. If the patient develops severe abdominal pain, worsening liver function, or signs of sepsis after the procedure, escalate care immediately for evaluation of complications like pancreatitis, cholangitis, or perforation.

Related ACR Topics and Tools

This article focuses on a single, specific clinical scenario. For a comprehensive overview of all variants and procedural ratings within this topic, or to explore different clinical presentations, the following resources are essential.

Frequently Asked Questions

Why is ERCP preferred over a percutaneous approach (PTC) if both are rated ‘Usually Appropriate’?

While both are effective, ERCP is generally preferred as the initial approach because it is less invasive, avoids an external drain which can affect quality of life, and carries a lower risk of bleeding. The percutaneous approach is an excellent and necessary alternative, especially when ERCP is technically not feasible (e.g., due to altered surgical anatomy like a Roux-en-Y) or if it fails.

What if the patient has a Roux-en-Y hepaticojejunostomy anastomosis?

A standard ERCP is not possible in patients with a Roux-en-Y reconstruction because the endoscope cannot reach the biliary anastomosis through the normal route. In these cases, the primary therapeutic procedure is Percutaneous Transhepatic Cholangiography (PTC) with drain placement. In some specialized centers, device-assisted enteroscopy ERCP may be an option, but PTC is more widely available and is the standard of care.

How long do the plastic biliary stents typically stay in place?

For a bile leak, a single stent is often removed after 4-8 weeks. For an anastomotic stenosis, treatment involves serial stenting, where stents are exchanged every 3-6 months. The total duration of therapy to successfully treat a stenosis can be 12 months or longer, depending on the severity and response to dilation.

If the ducts are not dilated, how does the interventional radiologist perform a percutaneous biliary drain?

Accessing non-dilated ducts percutaneously is technically challenging and requires significant expertise. The procedure is performed under ultrasound and fluoroscopic guidance. The radiologist targets a peripheral bile duct, often using specialized small-gauge needles. The success rate is lower and the complication risk (e.g., bleeding, pneumothorax) is higher than in patients with dilated ducts, which is another reason ERCP is often attempted first in this scenario.

Can Magnetic Resonance Cholangiopancreatography (MRCP) be used instead of an invasive procedure?

MRCP is an excellent non-invasive diagnostic tool that can visualize the biliary tree and often identify a stenosis. However, this specific ACR scenario is about the initial therapeutic procedure. While an MRCP might be performed as part of the diagnostic workup before the intervention, it cannot treat the problem. Since the clinical suspicion for a treatable lesion is high, proceeding directly to a therapeutic procedure like ERCP is often the most efficient pathway, as it combines diagnosis with immediate treatment.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 26, 2026